SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
"SonoMotion's technologies have the potential to be a first-line treatment for kidney stones, offering a solution for patients who want to avoid anesthesia ... (Asha), a life sciences company ...